Navigation Links
The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks
Date:5/21/2013

Toronto, Canada (PRWEB) May 21, 2013

As the R&D sector becomes increasingly competitive, there is a strong push within the industry to deliver better products, faster. Collaborations between Contract Development and Manufacturing Organizations and pharma companies often means turning big ideas into reality, within short time frames.

Microtablets, developed in collaboration with Sensidose AB and Recipharm, is one example of how effective outsourcing can bring products to market sooner. The partnership resulted in the development of a new dose automate delivery technology —slated to launch later this year— which can be customized to dispense medication according to individual requirement related to both dose amount and time.

In this webinar, keynote presenter Dr. Torkel Gren, Director at Recipharmm, will review how an effective collaboration between client and service provider can be achieved in outsourcing pharmaceutical development. The development of the microtablet, as well as how this concept can be used to develop new products of established active ingredients with a significantly improved therapeutic value, will be discussed.

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit: http://xtalks.com/Innovative-Microtablet-Dosage-Form-Development.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10737472.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development
2. Metabolic Solutions Development Company announces publication of data describing a new drug target for diabetes
3. Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
4. Winding River Productions Announces High-End Studio Enhancements Including SCORM-Compliant e-Learning Media Development and On-Location Data and Media Capture Platforms
5. Bayer CropScience Opens New Development North America Facilities in Research Triangle Park
6. Avenida Suites Hires Director for Global Business Development
7. A Media Event on Clinical Developments in Gene and Cell Therapy
8. Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
9. TessArae, LLC and Chinese esoteric laboratory, Kindstar Global, secure partnership for development of genetic tests.
10. Strategies for Rare Disease Studies and Orphan Drug Development in Europe; New Life Science Webinar Hosted by Xtalks
11. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... , ... Personal eye wash is a basic first aid supply for any work environment, but ... do you rinse first if a dangerous substance enters both eyes? It’s one less decision, ... its unique dual eye piece. , “Whether its dirt and debris, or an acid or ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published ... frozen and fresh in vitro fertilization (IVF) transfer cycles. The multi-center ... success. , After comparing the results from the fresh and frozen transfer cohorts, ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
Breaking Biology News(10 mins):